Last reviewed · How we verify
Caffeine Anhydrous with large sucrose pill — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Caffeine Anhydrous with large sucrose pill (Caffeine Anhydrous with large sucrose pill) — University of Colorado, Denver.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Caffeine Anhydrous with large sucrose pill TARGET | Caffeine Anhydrous with large sucrose pill | University of Colorado, Denver | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Caffeine Anhydrous with large sucrose pill CI watch — RSS
- Caffeine Anhydrous with large sucrose pill CI watch — Atom
- Caffeine Anhydrous with large sucrose pill CI watch — JSON
- Caffeine Anhydrous with large sucrose pill alone — RSS
Cite this brief
Drug Landscape (2026). Caffeine Anhydrous with large sucrose pill — Competitive Intelligence Brief. https://druglandscape.com/ci/caffeine-anhydrous-with-large-sucrose-pill. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab